Molecular Monitoring after Autologous Stem Cell Transplantation and Preemptive Rituximab Treatment of Molecular Relapse; Results from the Nordic Mantle Cell Lymphoma Studies (MCL2 and MCL3) with Median Follow-Up of 8.5 Years.
| Image |  |
|---|---|
| Description | scientific article published on 27 December 2016 |
| Author/s |
author: Christian W Eskelund Jan Delabie Kirsten Grønbæk Marja-Liisa Karjalainen-Lindsberg Riikka Räty Nordic Lymphoma Group Erkki Elonen Carsten Utoft Niemann Lone Bredo Pedersen Eva Kimby Arne Kolstad Mats Ehinger Mats Jerkeman Simon Ruben Husby Grete Fossum Lauritzsen Elisabeth Ralfkiaer Nils Hermann Nilsson-Ehle |
| Publication date | December 27, 2016 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |